iFIT has over 6.4 million total members, 1.5 million interactive fitness subscribers Celebrated NordicTrack’s 50th anniversary with Ultra 1 treadmill release In 120 countries Over 100 global retailers including Amazon, Costco, Dicks Sporting Goods, Best Buy, Fitshop, Decathlon, & John...

Visit Exec Edge Research for Full Report By Rayk Riechmann REX American Resources Corp. (NYSE: REX) beat EPS Street estimates by 133%, helping drive shares up 3.2% last week while the broader market struggled. On Wednesday REX announced 4Q results,...

By Karen Roman Yanolja Co., Ltd. said FY2024 total transaction value increased 186% to 27 trillion Won (USD 18.3 billion) compared to the year prior. Operating revenue rose 22% to reach 924.5 billion Won (USD 625.6 million), with enterprise solutions...

Contact: Executives-Edge.com Editor@executives-edge.com

By Karen Roman Abacus Global Management, Inc. (Nasdaq: ABL), a company focused on alternative asset management space, said fourth quarter revenue increased 40% to $33.2 million compared to $23.6 million the year prior. Adjusted net income was $13.4 million compared...

Visit Exec Edge Research for Full Report By Exec Edge Research Climb Bio, Inc. (Nasdaq: CLYM) reported full-year results, highlighting a healthy cash cushion and several milestones for investors to watch closely during the remainder of 2025. As we highlighted...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced positive data for NPM-139, its subdermal semaglutide implant for chronic weight management, with expected once or twice-yearly dosing. The results support the company’s NanoPortal implant for delivery of therapeutic molecules for...

Contact: Executives-Edge.com Rayk@capmarketsmedia.com

Tech Edge hosted a fireside chat on March 24 at Nasdaq MarketSite with Danny Brickman, Chief Executive Officer of Oasis Security. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed non-human identities and the security risks involved with...

By Karen Roman Private equity company Jeito Capital said it is co-leading an oversubscribed €77.7 million (USD 84.8 million) Series A financing round in Augustine Therapeutics. The founding will support Phase 2 of AGT-100216, Augustine’s main candidate for Charcot-Marie-Tooth disease...